Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

NCT03671291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 596

Last updated 2026-04-13

No results posted yet for this study

Summary

Missed opportunity to pre-exposure prophylaxis is a survey study that will be addressed to newly infected with human immunodeficiency virus (HIV) persons. The purposes of this study is to understand why despite the fact that pre-exposure prophylaxis exist, these persons have been contaminated with HIV.

Conditions

  • Virus-HIV

Interventions

BEHAVIORAL

self-administrated questionnaire

Persons who the biological parameters or past screening show that they were recently infected with HIV cf. eligibility criteria, will, after obtaining his consent, answer a series of questions through a self-administrated questionnaire that will take approximately 40 minutes.

Sponsors & Collaborators

  • University Hospital, Marseille

    collaborator OTHER
  • University Hospital, Grenoble

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER
  • University Hospital, Montpellier

    collaborator OTHER
  • Hospital Purpan

    collaborator OTHER
  • University Hospital, Bordeaux

    collaborator OTHER
  • Hôpital de la Croix-Rousse

    collaborator OTHER
  • Centre Hospitalier Universitaire Dijon

    collaborator OTHER
  • University Hospital of Saint-Etienne

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    collaborator OTHER
  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER
  • Tourcoing Hospital

    collaborator OTHER
  • University Hospital, Strasbourg

    collaborator OTHER
  • Nantes University Hospital

    collaborator OTHER
  • Centre Hospitalier Régional d'Orléans

    collaborator OTHER
  • Rennes University Hospital

    collaborator OTHER
  • Saint Antoine University Hospital

    collaborator OTHER
  • Tenon Hospital, Paris

    collaborator OTHER
  • Saint-Louis Hospital, Paris, France

    collaborator OTHER
  • Hôpital Necker-Enfants Malades

    collaborator OTHER
  • Bicetre Hospital

    collaborator OTHER
  • Pitié-Salpêtrière Hospital

    collaborator OTHER
  • Bichat Hospital

    collaborator OTHER
  • University Hospital Center of Martinique

    collaborator OTHER
  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Isabelle Poizot-Martin, Dr · Centre d'Informations et de soins de l'Immunodéficience Humaine et des hépatites Virales- CHU Sainte-Marguerite

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-03
Primary Completion
2020-10-03
Completion
2021-10-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03671291 on ClinicalTrials.gov